trial
-
Ampligen for ME/CFS
"PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017." "We have secured our first country approval for Ampligen® in ME/CFS and we expect several more in the coming years."...- Sly Saint
- Thread
- aim ampligen hemispherx biopharma me/cfs tba treatment trial
- Replies: 85
- Forum: ME/CFS research news
-
Clinical and cost-effectiveness of the Lightning Process ... for paediatric chronic fatigue syndrome, 2018, Crawley et al (Smile Trial)
Full open paper http://adc.bmj.com/content/early/2017/09/20/archdischild-2017-313375 (Moderator note: see this post for an alternative link to the paper and links to related threads)- Adrian
- Thread
- 2018 bps crawley economic impact lightning process paediatric paper smile smile trial trial
- Replies: 91
- Forum: Psychosomatic research - ME/CFS and Long Covid